Geratherm Medical Ag Stock Target Price
| GME Stock | 2.78 0.04 1.46% |
Geratherm Medical AG fundamentals help investors to digest information that contributes to Geratherm Medical's financial success or failures. It also enables traders to predict the movement of Geratherm Stock. The fundamental analysis module provides a way to measure Geratherm Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Geratherm Medical stock.
Geratherm |
Geratherm Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Geratherm Medical's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Geratherm Medical could also be used in its relative valuation, which is a method of valuing Geratherm Medical by comparing valuation metrics of similar companies.Geratherm Medical is currently under evaluation in target price category among its peers.
Geratherm Fundamentals
| Return On Equity | -0.011 | |||
| Return On Asset | 0.0028 | |||
| Profit Margin | (0) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 31.13 M | |||
| Shares Outstanding | 5.45 M | |||
| Shares Owned By Insiders | 70.08 % | |||
| Price To Book | 1.39 X | |||
| Price To Sales | 1.19 X | |||
| Revenue | 23.94 M | |||
| Gross Profit | 16.44 M | |||
| EBITDA | 1.96 M | |||
| Net Income | 122.23 K | |||
| Total Debt | 5.74 M | |||
| Book Value Per Share | 4.13 X | |||
| Cash Flow From Operations | 917 K | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 11.3 | |||
| Number Of Employees | 205 | |||
| Beta | 0.11 | |||
| Market Capitalization | 44.43 M | |||
| Total Asset | 34.56 M | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 34.56 M | |||
| Last Dividend Paid | 0.12 |
About Geratherm Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Geratherm Medical AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Geratherm Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Geratherm Medical AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Geratherm Stock Analysis
When running Geratherm Medical's price analysis, check to measure Geratherm Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Geratherm Medical is operating at the current time. Most of Geratherm Medical's value examination focuses on studying past and present price action to predict the probability of Geratherm Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Geratherm Medical's price. Additionally, you may evaluate how the addition of Geratherm Medical to your portfolios can decrease your overall portfolio volatility.